SHH and chronic myelogenous leukemia, BCR-ABL1 positive: In chronic myeloid leukemia and breast cancer, studies have found that Shh signaling is essential for maintenance of cancer stem cells and inhibition of the Shh pathway results in decreased stem cell propagation and renewal [14,58,59].